About

About
The DS management team has both a strong background in developing drugs for the market and experience in building life science companies.

Pipeline

Pipeline
DS Biopharma have two novel assets in various stages of clinical and pre-clinical development and intend to add more bioactive lipids to the current portfolio in the coming years.

Investors

Investors
To date, DS Biopharma have been funded privately.

Latest News

February 7, 2017

DS Biopharma appoints Jane Hollingsworth as Non-Executive Director

Dublin, Ireland, February 7, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced the appointment of Jane Hollingsworth as a non-executive director to […]
January 6, 2017

DS Biopharma (DS) announces that recruitment has begun in two separate Phase 2b atopic dermatitis studies with lead compound DS107 as well as the successful completion of a Phase 1 trial for follow on compound DS109

Dublin, Ireland, 6th January, 2017: DS Biopharma (DS), a privately held, clinical stage, pharmaceutical drug discovery and development company, today announced that recruitment has begun in […]

Join our mailing list

Connect with us